UK markets open in 2 hours 44 minutes

Edesa Biotech, Inc. (EDSA)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
4.6100+0.0600 (+1.32%)
At close: 04:00PM EDT
4.6600 +0.05 (+1.08%)
After hours: 04:03PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 14.83M
Enterprise value 10.64M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.54
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.88
52-week change 3-25.16%
S&P500 52-week change 326.27%
52-week high 38.3300
52-week low 32.4600
50-day moving average 34.4278
200-day moving average 34.6574

Share statistics

Avg vol (3-month) 39.77k
Avg vol (10-day) 33.72k
Shares outstanding 53.22M
Implied shares outstanding 63.24M
Float 82.33M
% held by insiders 128.45%
% held by institutions 110.73%
Shares short (30 Apr 2024) 416.13k
Short ratio (30 Apr 2024) 43.16
Short % of float (30 Apr 2024) 40.61%
Short % of shares outstanding (30 Apr 2024) 40.50%
Shares short (prior month 28 Mar 2024) 419.5k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 310 Jun 2019
Ex-dividend date 4N/A
Last split factor 21:7
Last split date 311 Oct 2023

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-55.76%
Return on equity (ttm)-95.77%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -8.58M
Net income avi to common (ttm)-7.72M
Diluted EPS (ttm)-20.1600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.27M
Total cash per share (mrq)1.35
Total debt (mrq)78.31k
Total debt/equity (mrq)1.34%
Current ratio (mrq)2.73
Book value per share (mrq)1.85

Cash flow statement

Operating cash flow (ttm)-6.25M
Levered free cash flow (ttm)-3.77M